£39.18

Springer Cardiac Management of Oncology Patients: Clinical Handbook for Cardio-Oncology

Price data last checked 89 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£39 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 2 days • 2 data points (No recent data available)

Historical
Generating forecast...
£39.18 £37.22 £38.00 £38.79 £39.57 £40.36 £41.14 11 March 2026 11 March 2026 11 March 2026 11 March 2026 12 March 2026

Price Distribution

Price distribution over 2 days • 1 price levels

Days at Price
2 days 0 1 1 2 2 £39 Days at Price

Price Analysis

Most common price: £39 (2 days, 100.0%)

Price range: £39 - £39

Price levels: 1 different prices over 2 days

Description

This book is designed for clinical cardiologists and other physicians working with cardiac patients, where specific specialized teams of cardio-oncologists are not available and who are called to perform a clinical consultation to evaluate both the cardiac condition and the eligibility for chemotherapy or radiotherapy treatment, and to evaluate if a cancer treatment produces toxic effects on a patient treated with chemo or radiotherapy and if appearance of new symptoms is due to this treatment. In recent years, progress in oncologic therapy has resulted in important developments and the prognostic improvement of patients with malignancy. The cornerstone of chemotherapy are the anthracyclines (and the analogue Mitoxantrone), that are direct cellular toxic agents and that are among the most powerful anti-neoplastic drugs, but their cardiac toxicity is well known. Significant breakthroughs in cancer therapy have also been achieved with the introduction of signalling inhibitors, such as VEGF inhibitors, HERB2 inhibitors or TK inhibitors used alone or in combination with direct cellular toxic drugs. However, these signalling inhibitors may interact also with cardiovascular signalling and therefore may have functional or structural effects on the myocardium. This can be permanent or reversible, with impairment of the global conditions and important side effects, and increase both morbidity and mortality and worsening of quality of life. Chemotherapy and radiotherapy can have acute detrimental effects that can be present for years after treatment and that can lead to cardiac consequences also after long periods of no clinic sequelae. Patient numbers with cancer problems will dramatically increase in the next years and thus every cardiologist will need to have the correct information and the skills to manage these situations in the correct way. This book will provide these tools for them.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 June 2015
Listed Since
21 January 2015

Barcode

No barcode data available

Similar Products You Might Like

Manual of Cardio-oncology: Cardiovascular Care in the Cancer Patient
98% match

Manual of Cardio-oncology: Cardiovascular Care in the Cancer Patient

Springer

£102.79 28 Feb 2026
Cardiotoxicity of Chemotherapeutic Agents (Cancer Etiology, Diagnosis and Treatments: Cardiology Research and Clinical Developments)
98% match

Cardiotoxicity of Chemotherapeutic Agents (Cancer Etiology, Diagnosis and Treatments: Cardiology Research and Clinical Developments)

£162.82 12 Jan 2026
Cardiotoxicity of Oncologic Treatments
98% match

Cardiotoxicity of Oncologic Treatments

£113.84 07 Jan 2026
Anti-Cancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions
98% match

Anti-Cancer Treatments and Cardiotoxicity: Mechanisms, Diagnostic and Therapeutic Interventions

Academic Press

£90.29 12 Apr 2026
Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease
97% match

Cardio-Oncology Practice Manual: A Companion to Braunwald's Heart Disease

Elsevier

£20.00 03 Apr 2026
Cardio-Oncology: Principles, Prevention and Management
97% match

Cardio-Oncology: Principles, Prevention and Management

Academic Press

£114.47 09 Mar 2026
Practical Cardio-Oncology
97% match

Practical Cardio-Oncology

CRC Press

£102.58 26 Feb 2026
Practical Cardio-Oncology
97% match

Practical Cardio-Oncology

CRC Press

£116.95 12 Jan 2026
Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology: From Basic Research to Advanced Study
97% match

Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-oncology: From Basic Research to Advanced Study

Academic Press

£101.96 09 Mar 2026
Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease
96% match

Cardio-Oncology: The Clinical Overlap of Cancer and Heart Disease

Springer

£91.92 08 Mar 2026
Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)
96% match

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

£418.38 11 Jan 2026
Clinical Cases in Cardio-Oncology
96% match

Clinical Cases in Cardio-Oncology

Springer

£56.97 08 Mar 2026
Handbook of Cancer Treatment-Related Symptoms and Toxicities
96% match

Handbook of Cancer Treatment-Related Symptoms and Toxicities

Elsevier

£66.35 12 Jan 2026
Springer Cancer Chemotherapy Volume 36 - Research Series
96% match

Springer Cancer Chemotherapy Volume 36 - Research Series

Springer

£113.25 05 Mar 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
96% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.09 28 Feb 2026
Cancer Chemotherapy 1: Cancer Treatment and Research: 7
96% match

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Springer

£166.09 09 Apr 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
96% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£215.71 11 Jan 2026
Cancer Imaging with Radiolabeled Antibodies: 51 (Cancer Treatment and Research, 51)
96% match

Cancer Imaging with Radiolabeled Antibodies: 51 (Cancer Treatment and Research, 51)

Springer

£245.82 22 Jan 2026
Wiley-Blackwell Cancer Consult: Expertise for Clinical Practice
96% match

Wiley-Blackwell Cancer Consult: Expertise for Clinical Practice

Wiley-Blackwell

£124.49 16 Apr 2026
Immunotoxins: 37 (Cancer Treatment and Research, 37)
96% match

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Springer

£240.00 25 Jan 2026
Holland-Frei Cancer Medicine - Volume 1 and 2
96% match

Holland-Frei Cancer Medicine - Volume 1 and 2

Wiley-Blackwell

£137.02 09 Dec 2025
Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)
96% match

Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)

Springer

£201.60 11 Jan 2026
Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)
96% match

Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)

Springer

£239.70 13 Feb 2026
Immunotoxins: 37 (Cancer Treatment and Research, 37)
96% match

Immunotoxins: 37 (Cancer Treatment and Research, 37)

Springer

£212.92 12 Jan 2026